RESEARCH-USE BIOSIMILAR ANTIBODY

Pexelizumab

Antibody fragment · Not specified

C5Not specifiedRUO

Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction.

TARGETC5
YAntibody fragment
CATALOGSC-BS-274
CATALOG NUMBERSC-BS-274
MOLECULAR WEIGHTApprox. 26.271 kDa
PRODUCT FORMATAntibody fragment

A research-use configuration for comparative antibody studies

Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction.

Pexelizumab is a recombinant research-use antibody directed against C5.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte